Biodexa Pharmaceuticals plc (BDRX) Net Income by Year
Biodexa Pharmaceuticals plc reported a net loss of $8.6M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Biodexa Pharmaceuticals plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BDRX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BDRX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Biodexa Pharmaceuticals plc financials
Frequently Asked Questions
What was Biodexa Pharmaceuticals plc's net income in fiscal year 2025?
Biodexa Pharmaceuticals plc reported a net loss of $8.6M in fiscal year 2025.
How fast is Biodexa Pharmaceuticals plc's net income growing?
Biodexa Pharmaceuticals plc (BDRX) reported a $7.2M net loss in fiscal year 2024 and a $8.6M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
How has Biodexa Pharmaceuticals plc's net income changed over the years?
Across the 11 fiscal years this page covers, Biodexa Pharmaceuticals plc (BDRX) net income went from -$14.9M in fiscal year 2015 to -$8.6M in fiscal year 2025.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Biodexa Pharmaceuticals plc (BDRX) reported on that line in every period on record.